RE:RE:RE:RE:RE:RE:RE:We shouldn't be in this position
I fully understand the specific knowledge difference between the two, and I thought O'Donnel delivered as more or more than anyone, but having your CEO, who also happens to be Chief Clinical Officer is not a negative, particularly given Berendt's background of success with the FDA. I am sure Monique C is capably knowledgeable, but that was an aggressive, even hostile environment and at times it seemed as if she were the solitary figure representing the corporation. Nothing more than that.